INNV: Ascending Triangle detected on 4 Mar 2026
Overall Score
79
of 100
Good
Win Probability
72%
High
Reward / Risk
1.1
: 1
$0.14 reward
$-0.13 risk
Current Setup
INNV is forming an ascending triangle breakout pattern at $9.49, after reporting fiscal Q2 revenue of $239.7M (+14.7% YoY) and returning to net income of $11.8M. The structure score of 13.75/15 reflects tight consolidation within defined support ($9.57) and resistance ($9.51). Breakout score of 11.7/13 suggests near-term triggering potential, while volume score of 10.2/12 indicates slightly below-average confirmation at 0.96x ratio. Pattern quality stands at 28.22 on the prior bull flag, with overall technical score of 78.65—solid but not exceptional. The setup benefits from strong 70.99% one-month and 79.73% three-month gains, though resistance remains compressed near current levels.
Stock Context
InnovAge raised fiscal 2026 revenue and Adjusted EBITDA guidance to $925M–$950M and $70M–$75M respectively, directly supporting near-term momentum. The stock hit a 52-week high of $9.64 on March 3, 2026, with a 190.33% year-long gain and 79% year-to-date gain, reflecting strong investor interest and market capitalization of $1.3 billion. Analysts have recently raised earnings estimates for both current quarter and full year, which appears to be a key catalyst for the stock. However, InvestingPro analysis indicates the stock appears overvalued at current levels. The healthcare sector itself trades in a bullish regime (0.41 score), supporting INNV's PACE expansion strategy during a favorable policy environment.
What to Expect
A successful breakout above $9.51 resistance would target 9.97 (conservative measured move), representing 5.1% upside from current levels. Volume confirmation remains critical—the pattern requires sustained volume above 0.96x average to validate breakout conviction. The stock recently approached its 52-week high of $9.64, making that level a secondary resistance zone. Invalidation occurs at support of 9.57; a close below this level would suggest the ascending triangle has failed. Win probability score of 72.26% indicates favorable historical odds, though the measured move target is modest given the tight consolidation range.
Risk Factors
RSI at 71.38 indicates overbought conditions, flagging potential pullback risk. Rising care costs, regulatory exposure, and de novo center losses present ongoing risks, and investors should focus on whether cost growth and new center losses can be contained despite higher guidance. Fair value estimates suggest potential 22% downside to current price, and InvestingPro analysis rates the stock as overvalued. Volume ratio of 0.96 is slightly below-average, reducing breakout confirmation strength. While beta of 0.57 is defensive, elevated volatility at 1.463 (20-day) combined with overbought RSI creates heightened risk of mean reversion. The market regime is bearish (-0.25 score), creating headwinds despite sector tailwinds.
Sources:
InnovAge Q2 2026 earnings call set for Feb. 3 | INNV Stock News
·
InnovAge Q2 revenue hits $239.7M, lifts 2026 view | INNV Stock News
·
Innovage stock hits 52-week high at $9.64 By Investing.com
·
INNV: InnovAge Holding Corp - Stock Price, Quote and News - CNBC
·
Buy Innovage Holding Corp Stock – INNV Stock Quote Today & Investment Insights - Public.com
·
INNV Stock Quote Price and Forecast | CNN
·
INNV Stock Price Quote | Morningstar
·
InnovAge (OTCMKTS:INNV) Reaches New 1-Year High - What's Next?
·
InnovAge Holding Corp. (INNV) Stock Price, News, Quote & History - Yahoo Finance
·
Innovage Holding Stock Forecast & Predictions: 1Y Price Target $5.00 | Buy or Sell NASDAQ: INNV 2026 | WallStreetZen
·
A Look At InnovAge Holding (INNV) Valuation As Upward Earnings Revisions Drive Strong Buy Rating - Simply Wall St News
·
InnovAge (INNV) Expands PACE Footprint and Revenue Growth Is Its Elder Care Strategy Taking Shape? - Simply Wall St News
·
InnovAge (INNV) Expands PACE Footprint and Revenue Growth Is Its Elder Care Strategy Taking Shape?
·
Investor Relations | InnovAge
·
InnovAge Holding Corp. - AnnualReports.com
·
__symbol__ Stock Quote Price and Forecast | CNN
·
InnovAge Holding 2025 Company Profile: Stock Performance & Earnings | PitchBook
·
The Bull Case For InnovAge Holding (INNV) Could Change Following Raised 2026 Revenue Guidance And Profit Return - Simply Wall St News
·
Check out InnovAge Holding Corp's stock price (INNV) in real time
·
InnovAge Holding Corp (INNV)
Market & Sector Regime
Market
Bearish
-0.25
-1.0
0
+1.0
Health Care Sector
Bullish
0.42
-1.0
0
+1.0
Other Patterns Detected Today
Bull Flag
20 days in pattern
Moderate
28.2
Overall Score
36
of 40
Pattern Quality
20
of 20
Setup
13
of 20
R/R
10
of 18
Context
Pattern Quality Score
14
of 15
Structure
12
of 13
Breakout
10
of 12
Volume
Recent Performance
Momentum & Trend
RSI (14)
71.4
Overbought
MACD Histogram
+0.04
Bullish
Bollinger Band Position
83.2%
Upper Zone
Volatility & Risk
20-Day Volatility
1.46
Very High
ATR %
6.9%
High
Beta
0.57
Below Mkt
Volume Analysis
Volume Ratio
0.96x
Average
20-Day Avg Vol
460K
shares / day
Current Volume
440K
shares traded
Price Levels
Target
$9.97
52W High
$9.76
Support
$9.57
Resistance
$9.51
Current
$9.49
Stop Loss
$8.43
52W Low
$2.60
Disclaimer: This analysis is algorithmically generated for educational purposes only and does not constitute financial advice. Past pattern performance does not guarantee future results. Win probabilities are based on historical data across 370,000+ observations. Always conduct your own research and consult a qualified financial advisor. AI-assisted contextual analysis by Claude (Anthropic). Indicators reflect values at time of detection.